A detailed history of Hughes Financial Services, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Hughes Financial Services, LLC holds 24 shares of ITCI stock, worth $3,164. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24
Holding current value
$3,164
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 01, 2025

BUY
$81.78 - $131.92 $1,962 - $3,166
24 New
24 $3.17 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12.4B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Hughes Financial Services, LLC Portfolio

Follow Hughes Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hughes Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hughes Financial Services, LLC with notifications on news.